Preservative-free latanoprost | IYUZEH™ (latanoprost ophthalmic ...
INDICATIONS AND USAGE. IYUZEH™ (latanoprost ophthalmic solution) 0.005% is a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure in …
IYUZEH™ Dosing and Administration
INDICATIONS AND USAGE. IYUZEH™ (latanoprost ophthalmic solution) 0.005% is a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure in …
Order IYUZEH and find patient access and affordability details ...
Thea’s Commitment to Access and Affordability. Thea Pharma Inc. is committed to helping patients get access to their medications. Thea’s Patient Assistance Program is intended for …
Frequently Asked Questions about IYUZEH™
Patients treated with either IYUZEH or XALATAN ® provided clinically meaningful reductions in IOP from baseline to all follow-up visits and time points (n=335). At day 84, the mean ± SD …
3 INDICATION FREQUENTLY ASKED QUESTIONS Q. What is the indication for IYUZEH™? A. IYUZEH (latanoprost ophthalmic solution) 0.005% is a prostaglandin F2α analogue indicated …
IYUZEH Safety & Tolerability | IYUZEH™ (latanoprost ophthalmic …
In clinical trials conducted with IYUZEH™ (latanoprost ophthalmic solution) 0.005% comparing it to XALATAN ®, the most frequently reported ocular adverse reactions were conjunctival …
IOP-lowering efficacy from latanoprost, without preservatives
References: 1. IYUZEH™ (latanoprost ophthalmic solution) 0.005%. Prescribing information. Thea Pharma Inc; 2024. 2. Bacharach J, Ahmed IIK, Sharpe ED, Korenfeld MS, Zhang S, …
E-Prescribe via EMR Pharmacy Name: PhilRx, LLC, Columbus, OH Type: Retail | NPI: 1487463598 Prefer to fax in prescriptions? Fax at (888) 975-0603 *PhilRx is a third-party …
Switching to preservative-free latanoprost - IYUZEH
The proportion of patients satisfied with preservative-free latanoprost ophthalmic solution 0.005% was similar among patients who had previously received preserved medication 95.3% …
IYUZEH sign up | IYUZEH™ (latanoprost ophthalmic solution) HCP
INDICATIONS AND USAGE. IYUZEH™ (latanoprost ophthalmic solution) 0.005% is a prostaglandin F2α analogue indicated for the reduction of elevated intraocular pressure in …